KLOW Blend 15mg — Vial Spec, Reconstitution Math & COA

Overview of KLOW Blend 15mg Specifications & Availability

The KLOW Blend 15mg specification represents a multi-component peptide matrix engineered for laboratory research evaluating extracellular matrix (ECM) remodeling, cellular migration, and localized inflammatory cascades. Synthesized as a lyophilized cake, a 15mg mass specification allows investigators to run acute, short-duration in vitro assays or limited animal model series without preparing excessive solution volumes that risk enzymatic degradation over extended storage periods.

While PX1 Research currently supplies this synergistic blend primarily in its high-capacity format as the KLOW Blend 80mg vial to support large-scale high-throughput screening, understanding the baseline mathematical calculations and solvent dynamics of a 15mg unit remains critical for bench researchers scaling protocols up or down. Researchers looking for single-target peptides or alternative formulations can also explore our complete catalog of all peptides for comparison.

Peptide Architecture: The Four-Phase KLOW Matrix

The KLOW designation corresponds to a rational combination of four well-characterized peptide sequences, each targeting distinct cellular receptors and biochemical pathways in preclinical models. The composite total peptide mass of 15mg is distributed among BPC-157, TB-500, GHK-Cu, and KPV in precise stoichiometry to enable concurrent pathway activation.

1. BPC-157 (Body Protection Compound 157): A pentadecapeptide derived from human gastric juice sequence, extensively studied in animal models for its interaction with the VEGFR2 pathway, focal adhesion kinase (FAK) phosphorylation, and accelerated tendon, ligament, and mucosal tissue healing.

2. TB-500 (Thymosin Beta-4 Fragment): A 43-amino-acid synthetic peptide sequence that sequesters G-actin monomers, promoting actin polymerization, cell motility, endothelial cell differentiation, and rapid vascular recruitment in wounded tissue beds.

3. GHK-Cu (Glycyl-L-histidyl-L-lysine Copper Complex): A naturally occurring tripeptide with high affinity for copper (II) ions, documented in preclinical models to modulate collagen synthesis (Types I, III, and V), upregulate glycosaminoglycan production, and reset gene expression profiles associated with oxidative stress.

4. KPV (Lysine-Proline-Valine): An alpha-MSH (Melanocyte-Stimulating Hormone) derived C-terminal tripeptide studied for its potent anti-inflammatory signalling via NF-κB inhibition and downregulation of pro-inflammatory cytokines such as IL-6 and TNF-alpha in cellular assays.

Reconstitution Mathematics & Concentration Calculations

Accurate volumetric reconstitution is necessary to maintain precise concentration management across working aliquots. When handling a 15mg total peptide lyophilized cake, the final working concentration (C) is calculated using the standard formula C = m / V, where m is total mass in milligrams (15mg) and V is the volume of bacteriostatic or sterile diluent added in milliliters.

To achieve reliable pipetting volumes in micro-assay setups, researchers must account for both solute displacement and target concentration parameters. For complex high-sensitivity assays, utilizing an automated tool like our inline reconstitution calculator ensures error-free conversion between milligrams, microliters, and final molarities.

Volumetric Dilution Matrix for 15mg Vials

The following parameters detail the resulting concentration metrics when reconstituting a 15mg KLOW Blend vial with standard diluent volumes of Bacteriostatic Water (0.9% Benzyl Alcohol) or Sterile Normal Saline (0.9% NaCl):

• 1.0 mL Diluent Addition: Yields a stock concentration of 15.0 mg/mL (15.0 µg/µL). This high-density stock is optimal for micro-volume microplate dosing (e.g., 1–5 µL additions per well) where liquid displacement must be minimized.

• 2.0 mL Diluent Addition: Yields a stock concentration of 7.5 mg/mL (7.5 µg/µL). This mid-tier dilution offers excellent balance between pipetting accuracy and vial headspace management for repetitive sampling.

• 3.0 mL Diluent Addition: Yields a stock concentration of 5.0 mg/mL (5.0 µg/µL). This concentration minimizes volumetric margin-of-error when delivering sub-milligram dosages in preclinical animal models requiring larger carrier volumes.

Handling, Aliquot Strategy, and Freeze-Thaw Prevention

Peptide matrices containing multi-component proteins like GHK-Cu and TB-500 are sensitive to shear forces and environmental degradation. Reconstitution should involve gently running the diluent down the glass vial wall, followed by smooth swirling—never violent shaking—to preserve secondary structure integrity.

Once reconstituted, repeated freeze-thaw cycles significantly increase peptide cleavage, aggregation, and loss of biological activity. Laboratory protocols should dictate immediate division of the stock solution into single-use, polypropylene low-binding micro-aliquots. Aliquots should be stored at -20°C or -80°C depending on the intended duration of the research project, thawing individual tubes immediately prior to assay execution.

Storage Protocols and Physicochemical Stability

Lyophilized Powder: Prior to reconstitution, unopened 15mg KLOW vials should be maintained at -20°C for long-term stability (up to 24 months) or 2°C to 8°C for short-term storage (up to 90 days). Vials must be protected from direct light exposure using dark storage boxes or amber containers.

Reconstituted Solution: Once dissolved in bacteriostatic water, liquid stock solutions remain stable at 2°C to 8°C for up to 28 days due to the antimicrobial preservation of benzyl alcohol. If dissolved in unpreserved sterile water or saline, solutions must be utilized within 24 hours or frozen instantly at -80°C.

Analytical Verification: Lot-Matched HPLC, Mass Spec, and COA Issuance

At PX1 Research, quality control is executed at every stage of synthesis and vial filling. Each production lot undergoes rigorous identity and purity testing in an ISO 17025 accredited laboratory to verify sequence integrity and component ratios.

Every batch is accompanied by a downloadable, lot-matched Certificate of Analysis containing High-Performance Liquid Chromatography (HPLC) chromatograms confirming overall purity ≥98%, along with Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weights. Furthermore, endotoxin testing (LAL assay) guarantees limits <0.01 EU/mg to eliminate confounding immune responses in sensitive cell cultures or animal models. Review detailed testing criteria on our dedicated COA verification hub.

Comparative Analysis: Selecting Between 15mg and 80mg Format Sizes

Choosing between a 15mg unit and a larger format like the 80mg vial depends entirely on experiment scale, budget management, and assay duration:

• 15mg Format Size: Best suited for pilot studies, method development, short-term cell viability assays, or laboratories testing small cohort numbers where unused liquid inventory would otherwise expire before consumption.

• 80mg Format Size: Designed for high-throughput screening, longitudinal animal models, or institutional research groups requiring consistent lot numbers across extensive testing runs. The larger fill size offers superior cost-per-milligram efficiency and reduced container packaging waste. Principal investigators managing large-scale operations can apply for dedicated institutional pricing via our wholesale portal.

Comparative Research Compounds in Biochemical Repair & Signal Cascades

When evaluating tissue repair mechanisms, researchers frequently compare multi-component formulations against standalone compounds to decipher synergistic versus isolated activity. For instance, standalone BPC-157 offers isolated angiogenic signaling without copper-mediated matrix crosslinking. Similarly, utilizing pure TB-500 allows isolated study of actin dynamics, while individual GHK-Cu focuses exclusively on gene regulation and remodeling.

In inflammatory research models, investigators often compare the peptide-based NF-κB suppression of KPV against broader cellular repair peptides to isolate precise anti-cytokine pathways. Reviewing our comprehensive research hub provides deeper literature background on structural repair and cellular migration kinetics across various peptide classes.

PX1 Research Quality Standards and Sourcing Assurance

PX1 Research operates strictly within GMP-compliant synthesis facilities located in the United States. Our peptide synthesis utilizes advanced solid-phase peptide synthesis (SPPS) protocols, followed by multi-stage purification and vacuum freeze-drying to ensure zero residual solvent contamination.

All order fulfillment originates directly from our domestic facilities in California and Arizona, providing same-day dispatch for orders finalized before standard cut-off times. Research institutes and universities receive direct chain-of-custody documentation, ensuring lot traceability and consistency from synthesis through delivery.